Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161263 · ClinicalTrials.gov registry record
Quality of Vision and Quality of Life With LASIK
A clinical trial of Myopia and Astigmatism, sponsored by Edward E. Manche.
- Completed
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT02161263 is a study of Myopia and Astigmatism that has completed, run by Edward E. Manche. The registered enrollment target is 49 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02161263, a study of Myopia and Astigmatism, has completed, sponsored by Edward E. Manche.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
Conditions Studied
Interventions
- OTHER Patient Quality of Life andVision after LASIK Surgery
Study Locations (1)
California
- Stanford Eye Laser Center - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2023-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02161263
The ClinicalTrials.gov registry entry for NCT02161263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (82% lower). The listed sponsor is Edward E. Manche, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Patient Quality of Life andVision after LASIK Surgery is the first listed.
NCT02161263 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02161263 about?
NCT02161263 is a clinical study titled "Quality of Vision and Quality of Life With LASIK". The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
What is the current status of trial NCT02161263?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2014-03-01. Estimated completion is 2023-02-01.
What conditions does trial NCT02161263 study?
This clinical trial studies the following conditions: Myopia, Astigmatism, Quality of Lifte.
What interventions are being tested in trial NCT02161263?
The interventions under investigation include: Patient Quality of Life andVision after LASIK Surgery (OTHER).
Who is sponsoring clinical trial NCT02161263?
This trial is sponsored by Edward E. Manche, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02161263 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.